Jiaqi Wang
Research Fellow
Research interest
Self-assembly peptide nanomaterials for precise theranosis of urological cancer
Education background
PhD, Harbin Medical University & National Center for Nanoscience and Technology, 2023
MSc, Harbin Medical University, 2019
Bsc, Harbin Medical University, I.M.Sechenov First Moscow State Medical University, 2016
E-mail: dnrv36@visitor.nus.edu.sg
Publication
Wang J#, Yang P#, Hou D#, Yan Y, Yue K, Zhong W, Xiao T, Wu X, Wang Z, Wu P, Wang L, Wang H, Xu W. Bacteria-inspired Transformable Nanoparticle Targets and Covers Residual Tumor against Bladder Cancer Recurrence. Nano Today. 2022 Aug;45: 101551.
Wang L#, Li C#, Wang J#, Yang G, Lv Y, Fu B, Jian L, Ma J, Yu J, Yang Z, Wu P, Li G, Liu X, Kang Z, Wang Z, Wang L, Wang H, Xu W. Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity. Adv Mater. 2022 Oct;34(43):e2203518.
Yan Y#, Wang J#, Zhang L#, Yang P, Ye X, Liu C, Hou D, Lai W, Wang J, Zeng X, Xu W, Wang L. Localized Instillation Enables In Vivo Screening of Targeting Peptides Using One-Bead One-Compound Technology. ACS Nano. 2023 Jan 3.
Mamuti M#, Wang Y#, Zhao Y#, Wang J#, Wang J, Fan Y, Xiao W, Hou D, Yang J, Zheng R, An H, Wang H. Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy. Adv Mater. 2022 Jun;34(24):e2109432.
Hou D#, Xiao W#, Wang J#, Yaseen M, Wang Z, Fei Y, Wang M, Wang L, Wang H, Shi X, Cai M, Feng H, Xu W, Li L. OGA Activated Glycopeptide-Based Nano-Activator to Activate PKM2 Tetramerization for Switching Catabolic Pathways and Sensitizing Chemotherapy Resistance. Biomaterials. 2022 May;284:121523.
Sun P, Wang J*, Ilyasova T, Shumadalova A, Agaverdiev M, Wang C. The function of miRNAs in the process of kidney development. Noncoding RNA Res. 2023 Aug 23;8(4):593-601.